|CrossRef Text and Data Mining|
|Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.|
|Fecal Calprotectin as a Surrogate Marker for Mucosal Healing After Initiating the Therapeutic Anti-Tubercular Trial|
|Clin Endosc 2022;55(2):210-212. Published online 2022 March 14 DOI: https://doi.org/10.5946/ce.2022.063|
Fecal Calprotectin as a Surrogate Marker for Mucosal Healing After Initiating the Therapeutic Anti-Tubercular Trial
P.11.9: Mucosal and Transmural Healing During Anti-Tnf Therapy. Is Fecal Calprotectin a Marker of Therapeutic Response?
Fecal Calprotectin Assay at an Early Stage of Treatment Can Be Used as a Surrogate Marker to Predict Clinical Remission and Mucosal Healing in Pediatric Crohn’s Disease
Fecal calprotectin is a clinically relevant biomarker of mucosal healing in patients with quiescent ulcerative colitis
OC3.03.8 IS FECAL CALPROTECTIN A MARKER FOR MUCOSAL HEALING DURING INFLIXIMAB THERAPY?
Value of Fecal Calprotectin Measurement During the Initial Period of Therapeutic Anti-Tubercular Trial
Fecal Calprotectin: A Reliable Predictor of Mucosal Healing after Treatment for Active Ulcerative Colitis
Clinical Value of Fecal Calprotectin in Predicting Mucosal Healing in Patients With Ulcerative Colitis
Tu1961 Fecal Immunochemical Test Versus Fecal Calprotectin for Prediction of Mucosal Healing in Crohn's Disease
Sa1049 Evaluation of Mucosal Healing in Ulcerative Colitis by Fecal Calprotectin Versus Fecal Immunochemical Test
|This metadata service is kindly provided by CrossRef from May 29, 2014. Clin Endosc has participated in CrossRef Text and Data Mining service since March 1, 2015.|